Washburn ML, Crosby R, Remlinger K, Wang F, Creech D. Therapeutically attenuating Neutrophil Recruitment with a CXCR2 antagonist in Combination with Oseltamivir ameliorates Influenza-Induced Lung Injury and Disease. Open Forum Infect Dis. 2019;6(4):ofz106.

Article  PubMed  PubMed Central  Google Scholar 

Rojas-Quintero J, Wan X, Tipper J, Burkett PR, Zuñiga J, Ashtekar AR, Polverino F, Rout A, Yambayev I, Hernández C, Jimenez L, Ramírez G, Harrod KS, Owen CA. Matrix metalloproteinase-9 deficiency protects mice from severe Influenza a viral Infection. Jci Insight. 2018;3(24).

hen X, Liu S, Goraya MU, Maarouf M, Huang S, Chen JL. Host Immune Response to Influenza A Virus Infection. Front Immunol. 2018;9:320.

Article  Google Scholar 

Denney L, Ho LP. The role of respiratory epithelium in host defence against Influenza virus Infection. Biomed J. 2018;41(4):218–33.

Article  PubMed  PubMed Central  Google Scholar 

Yang J, Huang YN, Liu SW. Investigational antiviral therapies for the treatment of Influenza. Expert Opin Investig Drugs. 2019;28(5):481–8.

Article  CAS  PubMed  Google Scholar 

Shie JJ, Fang JM. Development of effective anti-influenza Drugs: congeners and conjugates - a review. J Biomed Sci. 2019;26(1).

Yamayoshi S, Kawaoka Y. Current and future Influenza vaccines. Nat Med. 2019;25(2):212–20.

Article  CAS  PubMed  Google Scholar 

Zhong WT, Wu YC, Xie XX, Zhou X, Wei MM, Soromou LW, Ci XX, Wang DC. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-kappaB activation in acute lung injury mice. Fitoterapia. 2013;90:32–9.

Article  Google Scholar 

Jiang Q, Chen J, Long X, Yao X, Zou X, Yang Y, Huang G, Zhang H. Phillyrin protects mice from traumatic brain injury by inhibiting the inflammation of microglia via PPARgamma signaling pathway. Int Immunopharmacol. 2020;79:106083.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Ding Y, Zhao H, Wang Z, Zeng F, Qian Z, Li J, Ma T, Huang C. Downregulating PDPK1 and taking phillyrin as PDPK1-targeting drug protect hepatocytes from alcoholic steatohepatitis by promoting autophagy. Cell Death Dis. 2022;13(11):991.

Article  PubMed  PubMed Central  Google Scholar 

Qu XY, Li QJ, Zhang HM, Zhang XJ, Shi PH, Zhang XJ, Yang J, Zhou Z, Wang SQ. Protective effects of phillyrin against Influenza a virus in vivo. Arch Pharm Res. 2016;39(7):998–1005.

Article  CAS  PubMed  Google Scholar 

Khalil H, Abd El Maksoud AI, Roshdey T, El-Masry S. Guava flavonoid glycosides prevent Influenza a virus Infection via rescue of P53 activity. J Med Virol. 2019;91(1):45–55.

Article  CAS  PubMed  Google Scholar 

Maruyama H, Kimura T, Liu H, Ohtsuki S, Miyake Y, Isogai M, Arai F, Honda A. Influenza virus replication raises the temperature of cells. Virus Res. 2018;257:94–101.

Article  CAS  PubMed  Google Scholar 

Welleman V, Benhassou HA, Fuselier E, Bellesort F, Dury S, Lebargy F, Dormoy V, Fichel C, Naour RL, Gounni AS, Lamkhioued B. Role of CCR3 in respiratory syncytial virus Infection of airway epithelial cells. iScience. 2021;24(12):103433.

Article  Google Scholar 

Zhao X, Gu M, Xu X, Wen X, Yang G, Li L, Sheng P, Meng F. CCL3/CCR1 mediates CD14(+)CD16(-) circulating monocyte recruitment in knee osteoarthritis progression. Osteoarthritis Cartilage. 2020;28(5):613–25.

Article  CAS  PubMed  Google Scholar 

Zeng Z, Lan T, Wei Y, Wei X. CCL5/CCR5 axis in human Diseases and related treatments. Genes Dis. 2022;9(1):12–27.

Article  CAS  PubMed  Google Scholar 

Wang L, Zhang YL, Lin QY, Liu Y, Guan XM, Ma XL, Cao HJ, Liu Y, Bai J, Xia YL, Du J, Li HH. CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration. Eur Heart J. 2018;39(20):1818–31.

Article  CAS  PubMed  Google Scholar 

Korbecki J, Kojder K, Kapczuk P, Kupnicka P, Gawrońska-Szklarz B, Gutowska I, Chlubek D, Baranowska-Bosiacka I. The Effect of Hypoxia on the expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature. Int J Mol Sci. 2021;22(2).

Rudd JM, Pulavendran S, Ashar HK, Ritchey JW, Snider TA, Malayer JR, Marie M, Chow VTK, Narasaraju T. Neutrophils induce a Novel Chemokine receptors Repertoire during Influenza Pneumonia. Front Cell Infect Microbiol. 2019;9:108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Major J, Crotta S, Llorian M, McCabe TM, Gad HH, Priestnall SL, Hartmann R, Wack A. Type I and III interferons disrupt lung epithelial repair during recovery from viral Infection. Science. 2020;369(6504):712–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashar HK, Pulavendran S, Rudd JM, Maram P, Achanta M, Chow VTK, Malayer JR, Snider TA, Teluguakula N. Administration of a CXC chemokine receptor 2 (CXCR2) antagonist, SCH527123, together with Oseltamivir suppresses NETosis and protects mice from Lethal Influenza and piglets from Swine-Influenza Infection. Am J Pathol. 2021;191(4):669–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tavares LP, Garcia CC, Machado MG, Queiroz-Junior CM, Barthelemy A, Trottein F, Siqueira MM, Brandolini L, Allegretti M, Machado AM, de Sousa LP, Teixeira MM. CXCR1/2 antagonism is protective during Influenza and Post-influenza Pneumococcal Infection. Front Immunol. 2017;8:1799.

Article  PubMed  PubMed Central  Google Scholar 

Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng TK, Chan KH, Lai ST, Lim WL, Yuen KY, Guan Y. Re-emergence of fatal human Influenza a subtype H5N1 Disease. Lancet. 2004;363(9409):617–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qi JH, Dong FX, Wang K, Zhang SY, Liu ZM, Wang WJ, Sun FZ, Zhang HM, Wang XL. Feasibility analysis and mechanism exploration of Rhei Radix et Rhizome-Schisandrae Sphenantherae Fructus (RS) against COVID-19. J Med Microbiol. 2022;71(5).

Bai YL, Zhang JF, Sha ZJ, Zhu N, Huang XL, Li ZY. Study on potential molecular mechanism of Mongolian medicine Bawei Sanxiang San in treatment of chronic Heart Failure based on network pharmacology and molecular docking. Zhongguo Zhong Yao Za Zhi. 2021;46(10):2392–402.

PubMed  Google Scholar 

Tang H, Yang M, Liu Y, Liu H, Sun L, Song P. The CXCL1-CXCR2 Axis mediates tubular Injury in Diabetic Nephropathy through the regulation of the inflammatory response. Front Physiol. 2021;12:782677.

Article  PubMed  PubMed Central  Google Scholar 

McAuley JL, Tate MD, MacKenzie-Kludas CJ, Pinar A, Zeng W, Stutz A, Latz E, Brown LE, Mansell A. Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and Disease. PLoS Pathog. 2013;9(5):e1003392.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tate MD, Ong JDH, Dowling JK, McAuley JL, Robertson AB, Latz E, Drummond GR, Cooper MA, Hertzog PJ, Mansell A. Reassessing the role of the NLRP3 inflammasome during pathogenic Influenza a virus Infection via temporal inhibition. Sci Rep. 2016;6:27912.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ji S, Dai MY, Huang Y, Ren XC, Jiang ML, Qiao JP, Zhang WY, Xu YH, Shen JL, Zhang RQ, Fei GH. Influenza a virus triggers acute exacerbation of Chronic Obstructive Pulmonary Disease by increasing proinflammatory cytokines secretion via NLRP3 inflammasome activation. J Inflamm (Lond). 2022;19(1):8.

Article  CAS  PubMed  Google Scholar 

Bawazeer AO, Rosli S, Harpur CM, Docherty CA, Mansell A, Tate MD. Interleukin-1β exacerbates Disease and is a potential therapeutic target to reduce pulmonary inflammation during severe Influenza a virus Infection. Immunol Cell Biol. 2021;99(7):737–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qiu LN, Tan YR, Luo YJ, Chen XJ. Leonurine protects against Influenza a virus infection-induced Pneumonia in mice. Pathog Dis. 2021;79(7).

Hui DS, Lee N, Chan PK, Beigel JH. The role of adjuvant immunomodulatory agents for treatment of severe Influenza. Antiviral Res. 2018;150:202–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wan X, Li J, Wang Y, Yu X, He X, Shi J, Deng G, Zeng X, Tian G, Li Y, Jiang Y, Guan Y, Li C, Shao F, Chen H. H7N9 virus Infection triggers lethal cytokine Storm by activating gasdermin E-mediated pyroptosis of lung alveolar epithelial cells. Natl Sci Rev. 2022;9(1):nwab137.

Article  CAS  PubMed  Google Scholar 

Janssens Y, Joye J, Waerlop G, Clement F, Leroux-Roels G, Leroux-Roels I. The role of cell-mediated immunity against Influenza and its implications for vaccine evaluation. Front Immunol. 2022;13:959379.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine Storm. Microbiol Mol Biol Rev. 2012;76(1):16–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Sharma P, Jefferson M, Zhang W, Bone B, Kipar A, Bitto D, Coombes JL, Pearson T, Man A, Zhekova A, Bao Y, Tripp RA, Carding SR, Yamauchi Y, Mayer U, Powell PP, Stewart JP, Wileman T. Non-canonical autophagy functions of ATG16L1 in epithelial cells limit lethal Infection by Influenza a virus. Embo j. 2021;40(6):e105543.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kataoka M, Ishida K, Ogasawara K, Nozaki T, Satoh YI, Sata T, Sato Y, Hasegawa H, Nakajima N. Serial Section Array Scanning Electron Microscopy Analysis of Cells from lung autopsy specimens following fatal A/H1N1 2009 pandemic Influenza virus Infection. J Virol. 2019;93:19.

Article  Google Scholar 

Chen Y, Wu C, Li H, Powell H, Chen A, Zhu G, Cong W, Fu L, Pekosz A, Leng S. Antiviral effect and mechanism of Phillyrin and its reformulated FS21 against Influenza. Influenza Other Respir Viruses. 2023;17(3):e13112.

Article  CAS  PubMed